Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PBSV will - over the next 2 Weeks and hit - by . In that time frame, PBSV's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
PBSV shares remained flat 0 in Friday, May 29, 2026's trading session, starting and closing at a previous close of $0.57 to move at $0.57. The stock demonstrated notable intraday movement (see PBSV's key stats for a full breakdown), fluctuating between $0.57 and $0.57, a +0.88% trading range. While recent weeks have seen some volatility, PBSV has managed to secure a +10.86% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 3K shares changing hands, 2K more than the previous session. This amounted to $1.71K in total market activity.
Will PBSV Continue Its Trend?
According to analyst ratings and projections for PBSV, Pharma-Bio Serv, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PBSV currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the PBSV stock forecast, now is not the best time to buy PBSV stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PBSV covering social and institutional perspectives.
PBSV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PBSV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 63.42% to 65.03%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 54.80%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.29%, maintains a neutral outlook for the long term. Insights into PBSV's shareholder base show how institutional investors are positioning themselves during these momentum shifts

